Generic drug tariffs set to skyrocket in 2028. Consumers could feel impact

stabilize both the industry and the access necessary to ensure patients have reliable options for affordable medicines.”

Murphy added that generic manufacturing has “grown significantly in the U.S. over the past two years” but warned reimbursement for generics is “a significant inhibitor to the growth of this sector.”

Shift to domestic manufacturing continue reading …

ADVERTISEMENT

←PreviousNext→